-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
April 12, 2018 - women with osteoporosis defined by low bone density or by the presence of vertebral fractures found on screening … Before and throughout screening, team members will meet regularly to discuss study entry criteria, the … screening process and issues as they arise to ensure consistency within and between investigators. … Agency for Healthcare Research & Quality
ALP
alkaline phosphatase
BMD
bone mineral density
BMI … Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - women with osteoporosis defined by low bone density or by the
presence of vertebral fractures found on screening … Before and throughout screening, team members will meet regularly to
discuss study entry criteria, the … screening process and issues as they arise to ensure
consistency within and between investigators. … Agency for Healthcare Research & Quality
ALP alkaline phosphatase
BMD bone mineral density
BMI … [2] Assessment of fracture risk and its application to screening for postmenopausal
osteoporosis.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - women with osteoporosis defined by low bone density or by the
presence of vertebral fractures found on screening … Before and throughout screening, team members will meet regularly to
discuss study entry criteria, the … screening process and issues as they arise to ensure
consistency within and between investigators. … Agency for Healthcare Research & Quality
ALP alkaline phosphatase
BMD bone mineral density
BMI … [2] Assessment of fracture risk and its application to screening for postmenopausal
osteoporosis.
-
effectivehealthcare-admin.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
May 01, 2019 - All studies forwarded for full-text screening will be independently evaluated by two of six investigators … Before and throughout screening, team members will meet regularly to discuss study entry criteria, the … screening process and issues as they arise to ensure consistency within and between investigators. … fracture AHRQ Agency for Healthcare Research & Quality ALP alkaline phosphatase BMD bone mineral density BMI … Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
-
effectivehealthcare-admin.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
December 01, 2019 - adut men (age 45 years and over) with LUTS associated with BPH (i.e. defined by comorbidities [i.e., BMI … All studies identified as relevant by either investigator will undergo full-text screening. … Two investigators will independently perform full-text screening to determine if inclusion criteria are … Differences in screening decisions will be resolved by consultation between investigators, and, if necessary … Throughout the screening process, team members will meet regularly to discuss training material and issues
-
effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
April 24, 2015 - adut men (age 45 years and over) with LUTS associated with BPH (i.e. defined by comorbidities [i.e., BMI … All studies identified as relevant by either investigator will undergo full-text screening. … Two investigators will independently perform full-text screening to determine if inclusion criteria are … Differences in screening decisions will be resolved by consultation between investigators, and, if necessary … Throughout the screening process, team members will meet regularly to discuss training material and issues
-
www.ahrq.gov/research/findings/studies/index.html?page=49
January 01, 2024 - , Disparities
Adam GP , Pappas D , Papageorgiou H A novel tool that allows interactive screening … This study looked at a novel tool named Pythia that allows interactive screening of PubMed citations … A novel tool that allows interactive screening of PubMed citations showed promise for the semi-automation … post-discharge complication included female sex, ASA III/IV/V, dependent functional status, and higher BMI
-
effectivehealthcare-admin.ahrq.gov/products/peripheral-nerve-blocks/protocol
May 01, 2024 - To improve efficiency and accuracy of the screening process and management of the process, we will upload … all search results to a web-based screening tool, PICO Portal ™. … Citations identified by title/abstract will undergo full-text level screening by two team members independently … Participant baseline demographic and clinical characteristics including age, race/ethnicity, sex, BMI
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
January 01, 2019 - statement on Screening for Abnormal Blood Glucose and Type 2
Diabetes Mellitus. … ) and “at a lower body mass index” was
confirmed to mean that the younger woman’s body mass index (BMI … ) was not a factor to include
in the logic (as opposed to a BMI >=25 kilograms/meters squared for other … Screening for Abnormal Blood Glucose and
Type 2 Diabetes Mellitus: U.S. … for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part 1, Screening
2.3.3 Screening for Abnormal
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
January 01, 2019 - statement on Screening for Abnormal Blood Glucose and Type 2
Diabetes Mellitus. … ) and “at a lower body mass index” was
confirmed to mean that the younger woman’s body mass index (BMI … ) was not a factor to include
in the logic (as opposed to a BMI >=25 kilograms/meters squared for other … Screening for Abnormal Blood Glucose and
Type 2 Diabetes Mellitus: U.S. … for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part 1, Screening
2.3.3 Screening for Abnormal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Liver disease in Viet Nam: screening, surveillance,
management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening
with linkage to care in foreign-born … Targeted
hepatitis C screening among ex-injection drug users in the community. … Higher BMI
24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI
24-week fixed duration triple therapy with
telaprevir, pegylated interferon alfa-2b, and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Liver disease in Viet Nam: screening, surveillance,
management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening
with linkage to care in foreign-born … Targeted
hepatitis C screening among ex-injection drug users in the community. … Higher BMI
24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI
24-week fixed duration triple therapy with
telaprevir, pegylated interferon alfa-2b, and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Liver disease in Viet Nam: screening, surveillance,
management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening
with linkage to care in foreign-born … Targeted
hepatitis C screening among ex-injection drug users in the community. … Higher BMI
24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI
24-week fixed duration triple therapy with
telaprevir, pegylated interferon alfa-2b, and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Liver disease in Viet Nam: screening, surveillance,
management and education: a 5-year plan and call … Hepatitis Outreach Network: a practical strategy for hepatitis screening
with linkage to care in foreign-born … Targeted
hepatitis C screening among ex-injection drug users in the community. … Higher BMI
24-week fixed duration triple therapy with telaprevir, pegylated interferon alfa-2b, and … Higher BMI
24-week fixed duration triple therapy with
telaprevir, pegylated interferon alfa-2b, and
-
www.qualitymeasures.ahrq.gov/ncepcr/tools/obesity-kit/obtoolkit3.html
March 01, 2014 - (In such a case, querying by body mass index (BMI) or the ICD-9 code for unspecified obesity would likely … Consider putting community resource signs or a BMI poster above the scale. … on a specific component of the visit, such as making sure every patient understands the meaning of BMI
-
ce.effectivehealthcare.ahrq.gov/ncepcr/tools/obesity-kit/obtoolkit3.html
March 01, 2014 - (In such a case, querying by body mass index (BMI) or the ICD-9 code for unspecified obesity would likely … Consider putting community resource signs or a BMI poster above the scale. … on a specific component of the visit, such as making sure every patient understands the meaning of BMI
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - General adverse events include:
• Extrapyramidal effects
• Weight gain (e.g., using Body Mass Index (BMI … response, remission, relapse,
speed of response, time to discontinuation of medication;
• Growth (using BMI … arrhythmias, agranulocytosis;
• General adverse events: extrapyramidal effects, weight gain (e.g., using BMI
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - phototherapy
a Key Question abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; BMI … anemia,
neutropenia], hypertension, alteration in metabolic
parameters [e.g., glucose, lipids, weight, BMI … Acronyms/Abbreviations
ALT alanine aminotransferase
AST aspartate aminotransferase
BMI body mass
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - phototherapy
a Key Question abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; BMI … anemia,
neutropenia], hypertension, alteration in metabolic
parameters [e.g., glucose, lipids, weight, BMI … Acronyms/Abbreviations
ALT alanine aminotransferase
AST aspartate aminotransferase
BMI body mass
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - General adverse events include:
• Extrapyramidal effects
• Weight gain (e.g., using Body Mass Index (BMI … response, remission, relapse,
speed of response, time to discontinuation of medication;
• Growth (using BMI … arrhythmias, agranulocytosis;
• General adverse events: extrapyramidal effects, weight gain (e.g., using BMI